![Dannielle Appelhans](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dannielle Appelhans
Director/Board Member at
HALOZYME THERAPEUTICS, INC.
Profile
Dannielle Appelhans is President, Chief Executive Officer & Director at Cour Pharmaceuticals Development Co., Inc. since 2024.
Ms. Appelhans is Director at Halozyme Therapeutics, Inc. starting in 2026.
Former roles include President & Chief Executive Officer at Rubius Therapeutics, Inc. from 2022 to 2023, Independent Director at Generation Bio Co. from 2022 to 2026, Senior Manager-Engagement at McKinsey & Co., Inc. from 2011 to 2014, and Chief Technical Officer at Novartis Gene Therapies, Inc. from 2020 to 2021.
Education includes graduate studies at Massachusetts Institute of Technology, undergraduate studies at the University of Michigan, and an MBA from MIT Sloan School of Management.
Dannielle Appelhans active positions
| Companies | Position | Start |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Director/Board Member | 13/08/2026 |
Cour Pharmaceuticals Development Co., Inc.
 Cour Pharmaceuticals Development Co., Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes biopharmaceuticals to treat autoimmune diseases | Chief Executive Officer | 31/08/2024 |
Former positions of Dannielle Appelhans
| Companies | Position | End |
|---|---|---|
| GENERATION BIO CO. | Director/Board Member | 05/02/2026 |
| RUBIUS THERAPEUTICS | Chief Executive Officer | 02/03/2023 |
| AVEXIS INC | Chief Tech/Sci/R&D Officer | 31/12/2020 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | 30/11/2014 |
Training of Dannielle Appelhans
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
62
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Cour Pharmaceuticals Development Co., Inc.
Cour Pharmaceuticals Development Co., Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes biopharmaceuticals to treat autoimmune diseases | Health Technology |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Develops red cell therapeutics for cancer treatment | Health Technology |
Generation Bio Co.
 Generation Bio Co. Pharmaceuticals: MajorHealth Technology Develops and commercializes genetic medicines | Health Technology |
- Stock Market
- Insiders
- Dannielle Appelhans
